5-Amino-1MQ 50mg
| Report | #36784 |
|---|---|
| Batch | FTD1165 |
| Quantity | 51.94mg |
| Purity | 99.409% |
| Analysed | 07/04/26 |
| Method | RP-HPLC / UV |

Batch FTD1165
Independent analysis by Chromate. Every figure below is taken directly from the report shown.
| Report | #36784 |
|---|---|
| Batch | FTD1165 |
| Quantity | 51.94mg |
| Purity | 99.409% |
| Analysed | 07/04/26 |
| Method | RP-HPLC / UV |

| Report | #36817 |
|---|---|
| Batch | FTD1165 |
| Quantity | 10.82mg |
| Purity | 97.474% |
| Analysed | 07/04/26 |
| Method | RP-HPLC / UV |

| Report | #37383 |
|---|---|
| Batch | FTD1165 |
| Quantity | 4.966mg |
| Purity | 96.178% |
| Analysed | 07/21/26 |
| Method | RP-HPLC / UV |

| Report | #37808 |
|---|---|
| Batch | FTD1165 |
| Quantity | 8.512mg |
| Purity | 98.020% |
| Analysed | 07/16/26 |
| Method | HILIC-HPLC / UV |

| Report | #37680 |
|---|---|
| Batch | FTD1165 |
| Quantity | 46.67mg |
| Purity | 99.843% |
| Analysed | 07/28/26 |
| Method | HPLC / UV-Vis |

| Report | #36806 |
|---|---|
| Batch | FTD1165 |
| Quantity | 4.708mg |
| Purity | 99.658% |
| Analysed | 07/03/26 |
| Method | RP-HPLC / UV |

| Report | #36818 |
|---|---|
| Batch | FTD1165 |
| Quantity | 10.97mg |
| Purity | 98.207% |
| Analysed | 07/05/26 |
| Method | RP-HPLC / UV |

| Report | #36807 |
|---|---|
| Batch | FTD1165 |
| Quantity | 9.263mg |
| Purity | 99.316% |
| Analysed | 07/02/26 |
| Method | RP-HPLC / UV |

| Report | #37502 |
|---|---|
| Batch | FTD1165 |
| Quantity | 462.1mg |
| Purity | 93.957% |
| Analysed | 07/24/26 |
| Method | RP-HPLC / UV |
NAD+ is inherently unstable and assays alongside its own degradation products (ADP-ribose, nicotinamide, NMN, AMP). The lab notes this on the certificate.

| Report | #36777 |
|---|---|
| Batch | FTD1165 |
| Quantity | 10.59mg |
| Purity | 99.831% |
| Analysed | 07/03/26 |
| Method | RP-HPLC / UV |

| Report | #37476 |
|---|---|
| Batch | FTD1165 |
| Quantity | 47.22mg |
| Purity | 99.536% |
| Analysed | 07/22/26 |
| Method | RP-HPLC / UV |

| Report | #37477 |
|---|---|
| Batch | FTD1165 |
| Quantity | 19.16mg |
| Purity | 99.219% |
| Analysed | 07/22/26 |
| Method | RP-HPLC / UV |

| Report | #37503 |
|---|---|
| Batch | FTD1165 |
| Quantity | 9.865mg |
| Purity | 98.668% |
| Analysed | 07/23/26 |
| Method | RP-HPLC / UV |

| Report | #36901 |
|---|---|
| Batch | FTD1165 |
| Quantity | 9.947mg |
| Purity | 99.719% |
| Analysed | 07/05/26 |
| Method | RP-HPLC / UV |
The report header reads “30mg” in error; the measured 9.947mg confirms the 10mg vial. A corrected report has been requested.

| Report | #36905 |
|---|---|
| Batch | FTD1165 |
| Quantity | 10.78mg |
| Purity | 98.126% |
| Analysed | 07/04/26 |
| Method | RP-HPLC / UV |

| Report | #36775 |
|---|---|
| Batch | FTD1165 |
| Quantity | 10.09mg |
| Purity | 99.326% |
| Analysed | 07/03/26 |
| Method | RP-HPLC / UV |
